CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,385,038 | +188.3% | 329,771 | +312.5% | 0.00% | – |
Q4 2022 | $480,415 | -78.4% | 79,936 | -79.1% | 0.00% | -100.0% |
Q3 2022 | $2,227,000 | +99.2% | 382,686 | +104.2% | 0.00% | – |
Q2 2022 | $1,118,000 | -31.6% | 187,403 | -46.5% | 0.00% | – |
Q1 2022 | $1,635,000 | +514.7% | 350,283 | +226.0% | 0.00% | – |
Q4 2021 | $266,000 | +421.6% | 107,449 | +520.4% | 0.00% | – |
Q3 2021 | $51,000 | +54.5% | 17,319 | +11.6% | 0.00% | – |
Q3 2020 | $33,000 | -72.3% | 15,519 | -88.8% | 0.00% | – |
Q2 2019 | $119,000 | +1222.2% | 138,330 | +998.5% | 0.00% | – |
Q4 2018 | $9,000 | -98.1% | 12,593 | -92.9% | 0.00% | -100.0% |
Q4 2017 | $472,000 | +102.6% | 176,171 | +218.0% | 0.00% | 0.0% |
Q1 2017 | $233,000 | – | 55,393 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
Knott David M Jr | 221,079 | $548,000 | 0.19% |
Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |